These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
519 related items for PubMed ID: 16934609
1. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions. Borrelli V, di Marzo L, Sapienza P, Colasanti M, Moroni E, Cavallaro A. Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609 [Abstract] [Full Text] [Related]
2. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Piagnerelli R, Cavallaro A. Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):89-97. PubMed ID: 15177237 [Abstract] [Full Text] [Related]
3. Metalloproteinases and their inhibitors are markers of plaque instability. Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Cresti S, Cavallaro A. Surgery; 2005 Mar; 137(3):355-63. PubMed ID: 15746792 [Abstract] [Full Text] [Related]
4. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells. Ito I, Fixman ED, Asai K, Yoshida M, Gounni AS, Martin JG, Hamid Q. Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858 [Abstract] [Full Text] [Related]
5. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells]. Zhang JJ, Wang B. Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888 [Abstract] [Full Text] [Related]
6. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM. J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [Abstract] [Full Text] [Related]
7. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis. Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P. Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957 [Abstract] [Full Text] [Related]
8. The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Jiang X, Zeng HS, Guo Y, Zhou ZB, Tang BS, Li FK. Chin Med J (Engl); 2004 Dec; 117(12):1825-9. PubMed ID: 15603712 [Abstract] [Full Text] [Related]
9. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Fujiwara M, Muragaki Y, Ooshima A. Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739 [Abstract] [Full Text] [Related]
10. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein]. Huang HC, Liu SY, Liang Y, Liu Y, Li JZ, Wang HY. Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):328-31. PubMed ID: 15854510 [Abstract] [Full Text] [Related]
11. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis]. Li Q, Zhou X, Yu J, Qian W, Xu KS. Zhonghua Yi Xue Za Zhi; 2008 May 13; 88(18):1273-8. PubMed ID: 18844103 [Abstract] [Full Text] [Related]
12. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Cuccurullo C, Iezzi A, Fazia ML, De Cesare D, Di Francesco A, Muraro R, Bei R, Ucchino S, Spigonardo F, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A, Cipollone F. Arterioscler Thromb Vasc Biol; 2006 Dec 13; 26(12):2716-23. PubMed ID: 17038636 [Abstract] [Full Text] [Related]
13. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R. J Pharmacol Exp Ther; 2006 Jan 13; 316(1):8-16. PubMed ID: 16166267 [Abstract] [Full Text] [Related]
14. AP-1 inhibits expression of MMP-2/9 and its effects on rat smooth muscle cells. Zhang HW, Wang X, Zong ZH, Huo X, Zhang Q. J Surg Res; 2009 Nov 13; 157(1):e31-7. PubMed ID: 19524937 [Abstract] [Full Text] [Related]
15. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture. Borrelli V, Sterpetti AV, Coluccia P, Randone B, Cavallaro A, Santoro D'Angelo L, Cucina A. J Surg Res; 2001 Oct 13; 100(2):154-60. PubMed ID: 11592785 [Abstract] [Full Text] [Related]
16. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M, Muragaki Y, Ooshima A. Arch Dermatol Res; 2005 Oct 13; 297(4):161-9. PubMed ID: 16184401 [Abstract] [Full Text] [Related]
17. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Braundmeier AG, Nowak RA. Am J Reprod Immunol; 2006 Sep 13; 56(3):201-14. PubMed ID: 16911716 [Abstract] [Full Text] [Related]
18. Elevated D-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Phillips AO, Steadman R, Topley N, Williams JD. Am J Pathol; 1995 Aug 13; 147(2):362-74. PubMed ID: 7639330 [Abstract] [Full Text] [Related]
19. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. Ylä-Outinen H, Aaltonen V, Björkstrand AS, Hirvonen O, Lakkakorpi J, Vähä-Kreula M, Laato M, Peltonen J. J Invest Dermatol; 1998 Mar 13; 110(3):232-7. PubMed ID: 9506441 [Abstract] [Full Text] [Related]
20. Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression. Sapienza P, Borrelli V, Sterpetti AV, Dinicola S, Tartaglia E, di Marzo L. Ann Vasc Surg; 2011 Aug 13; 25(6):823-9. PubMed ID: 21620672 [Abstract] [Full Text] [Related] Page: [Next] [New Search]